Hart D, Shochat E, Agur Z
Department of Zoology, Tel-Aviv University, Ramat-Aviv, Israel.
Br J Cancer. 1998 Aug;78(3):382-7. doi: 10.1038/bjc.1998.503.
Despite considerable progress in understanding tumour development, the law of growth for human tumours is still a matter of some dispute. In this study, we used large-scale mammography screening trial data to deduce the growth law of primary breast cancer. We compared the empirical tumour population size distributions of primary breast cancer inferred from these data to the distributions that correspond to various possible theoretical growth functions. From this, we showed that the data are inconsistent with the exponential, logistic and Gompertz laws, but support power law growth (exponent approximately 0.5). This law indicates unbounded growth but with slowing mass-specific growth rate and doubling time. In the clinical size ranges, it implies a greater decline in the mass-specific growth rate than would be predicted by the Gompertz law using the accepted parameters. This suggests that large tumours would be less sensitive to cycle-specific therapies, and be better treated first by non-cell cycle-specific agents. We discussed the use of our study to estimate the sensitivity of mammography for the detection of small tumours. For example, we estimated that mammography is about 30% less sensitive in the detection of tumours in the 1 to 1.5-cm range than it is in detecting larger tumours.
尽管在理解肿瘤发展方面取得了相当大的进展,但人类肿瘤的生长规律仍然存在一些争议。在本研究中,我们使用大规模乳腺钼靶筛查试验数据来推导原发性乳腺癌的生长规律。我们将从这些数据推断出的原发性乳腺癌的经验性肿瘤群体大小分布与对应于各种可能理论生长函数的分布进行了比较。由此,我们表明这些数据与指数、逻辑斯蒂和冈珀茨定律不一致,但支持幂律生长(指数约为0.5)。该定律表明生长无界,但质量比生长速率和倍增时间会减缓。在临床大小范围内,这意味着质量比生长速率的下降幅度比使用公认参数的冈珀茨定律所预测的更大。这表明大肿瘤对细胞周期特异性疗法的敏感性较低,最好先用非细胞周期特异性药物进行治疗。我们讨论了利用我们的研究来估计乳腺钼靶检测小肿瘤的敏感性。例如,我们估计乳腺钼靶在检测1至1.5厘米范围内的肿瘤时,其敏感性比检测较大肿瘤时低约30%。